Ringer's lactate improves liver recovery in a murine model of acetaminophen toxicity

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Yang, Runkuan ^a,c   Zhang, Shutian ^b   Kajander, Henri ^c   Zhu, Shengtao ^b   Koskinen, Marja Leena ^c   Tenhunen, Jyrki ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Friendship Hospital   (China)

^c UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLIN D1; CYCLINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELOPEROXIDASE; PARACETAMOL; RINGER LACTATE SOLUTION; TUMOR NECROSIS FACTOR ALPHA; ANALGESIC AGENT; ISOTONIC SOLUTION; RINGER'S LACTATE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA BINDING; FLUID THERAPY; GEL MOBILITY SHIFT ASSAY; HISTOPATHOLOGY; LIVER REGENERATION; LIVER TOXICITY; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; THERAPY EFFECT; TOXIC HEPATITIS; TOXICITY TESTING; WESTERN BLOTTING; ANIMAL; BLOOD; C57BL MOUSE; INTOXICATION; LIVER; METABOLISM; PROTEIN BINDING;

ACETAMINOPHEN; ALANINE TRANSAMINASE; ANALGESICS, NON-NARCOTIC; ANIMALS; ASPARTATE AMINOTRANSFERASES; CYCLIN D1; DRUG-INDUCED LIVER INJURY; ISOTONIC SOLUTIONS; LIVER; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; OVERDOSE; PROTEIN BINDING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81055149723     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-125     Document Type: Article

References (40)

1. Lee WM. Acetaminophen and the U.S. Acute liver failure study group: lowering the risks of hepatic failure. Hepatology 2004, 40:6-9.
2. Nelson SD. Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 1990, 10:267-278. 10.1055/s-2008-1040482, 2281334.
3. Cohen SD, Khairallah EA. Selective protein arylation and acetaminophen- induced hepatotoxicity. Drug Metab Rev 1997, 29:59-77. 10.3109/03602539709037573, 9187511.
4. Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective Hepatocyte regeneration in interleukin-6 deficient mice. Science 1996, 274:1379-83. 10.1126/science.274.5291.1379, 8910279.
5. Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 2006, 89:31-41.
6. Chanda S, Mehendale HM. Hepatic cell division and tissue repair: a key to survival after liver injury. Mol Med Today 1996, 2:82-89. 10.1016/1357-4310(96)88743-0, 8796861.
7. Mehendale HM. Tissue repair: An important determinant of final outcome of toxicant-induced injury. Toxicol Pathol 2005, 33:41-51. 10.1080/01926230590881808, 15805055.
8. Fausto N. Liver regeneration. J Hepatology 2000, 32:19-31.
9. Akerman P, Coto P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992, 263:G579-G585.
10. Cataldegirmen G, Zeng S, Feirt N, Ippagunta N, Dun H, Qu W, Lu Y, Rong L, Hofmann MA, Kislinger T, Pachydaki SI, Jenkins DG, Weinberg A, Lefkowitch J, Rogiers X, Yan S, Schmidt AM, Emond JC. Rage limits regeneration after massive liver injury by coordinated suppression of TNF-α and NF-κB. JEM 2005, 201:473-484.
11. Hogaboam CM, Bone-Larson CL, Steinhauser ML, Lucas NW, Colletti LM, Simpson KJ, Strieter RM, Kunkel SL. Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines. FASEB 1999, 13:1565-1574.
12. Lang K, Suttner S, Boldt J, Kumle B, Nagel D. Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery. Can J Anaesth 2003, 50:1009-1016. 10.1007/BF03018364, 14656778.
13. Tamayo E, Alvarez FJ, Alonso O, Castrodeza J, Bustamante R, Gomez-Herreras JI, Florez S, Rodriguez R. The inflammatory response to colloids and crystalloids used for pump priming during cardiopulmonary bypass. Acta Anaesthesiol Scand 2008, 52:1204-12. 10.1111/j.1399-6576.2008.01758.x, 18823458.
14. Deree J, Loomis WH, Wolf P, Coimbra R. Hepatic transcription factor activation and proinflammatory mediator production is attenuated by hypertonic saline and pentoxifylline resuscitation after hemorrhagic shock. J Trauma 2008, 64:1230-8. 10.1097/TA.0b013e31816a4391, 18469645.
15. King P, Kong MF, Parkin H, MacDonald IA, Barber C, Tattersall RB. Intravenous lactate prevents cerebral dysfunction during hypoglycaemia in insulin-dependent diabetes mellitus. Clin Sci (Lond) 1998, 94:157-163.
16. Maran A, Crepaldi C, Trupiani S, Lucca T, Jori E, Macdonald IA, Tiengo A, Avogaro A, Del Prato S. Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and type I diabetic subjects. Diabetologia 2000, 43:733-741. 10.1007/s001250051371, 10907119.
17. Maran A, Cranston I, Lomas J, Macdonald I, Amiel SA. Protection by lactate of cerebral function during hypoglycaemia. Lancet 1994, 343:16-20. 10.1016/S0140-6736(94)90876-1, 7905041.
18. Schurr A. Lactate: the ultimate cerebral oxidative energy substrate?. J Cereb Blood Flow Metab 2006, 26:142-152. 10.1038/sj.jcbfm.9600174, 15973352.
19. Schurr A, Payne RS, Miller JJ, Rigor BM. Brain lactate is an obligatory aerobic energy substrate for functional recovery after hypoxia: further in vitro validation. Neurochem 1997, 69:423-426.
20. Rice AC, Zsoldos R, Chen T, Wilson MS, Alessandri B, Hamm RJ, Bullock MR. Lactate administration attenuates cognitive deficits following traumatic brain injury. Brain Res 2002, 928:156-159. 10.1016/S0006-8993(01)03299-1, 11844482.
21. Philp A, Macdonald AL, Watt PW. Lactate-a signal coordinating cell and systemic function. J Exp Biol 2005, 208:4561-4575. 10.1242/jeb.01961, 16326938.
22. Leverve XM. Energy metabolism in critically ill patients: lactate is a major oxidizable substrate. Curr Opin Clin Nutr Metab Care 1999, 2:165-169. 10.1097/00075197-199903000-00013, 10453349.
23. Leverve XM, Mustafa I, Peronnet F. Pivotal role of lactate in aerobic metabolism. Year book of intensive care and emergency medicine 1998, 588-596. J.V. Springer, Berlin.
24. Schurr A. Lactate, glucose and energy metabolism in the ischemic brain (Review). Int J Mol Med 2002, 10:131-136.
25. Schurr A, Payne RS, Miller JJ, Rigor BM. Brain lactate, not glucose, fuels the recovery of synaptic function from hypoxia upon reoxygenation: an in vitro study. Brain Res 1997, 744:105-111. 10.1016/S0006-8993(96)01106-7, 9030418.
26. Levy B, Mansart A, Montemont C, Gibot S, Mallie JP, Regnault V, Lecompte T, Lacolley P. Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energies, and early death in endotoxic shock. Intensive Care Med 2007, 33:495-502. 10.1007/s00134-006-0523-9, 17242933.
27. Martinez-Mier G, Toledo-Pereyra LH, McDuffie E, Warner RL, Ward PA. L- selectin and chemokine response after liver ischemia and reperfusion. JSR 2000, 93:156-162. 10.1006/jsre.2000.5954, 10945958.
28. Yang R, Gallo DJ, Baust JJ, Uchiyama T, Watkins SK, Delude RL, Fink MP. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 2002, 283:G212-G22.
29. Yang R, Harada T, Mollen KP, Prince JM, Levy RM, Englert JA, Galloitsch-Peerta M, Yang L, Yang H, Tracey KJ, Harbrecht BG, Billiar TR, Fink MP. Anti- HMGB1 neutralizing antibody ameliorates gut barrier Dysfunction and improves survival after hemorrhagic shock. Mol Med 2006, 12:105-14. 1578769, 16953558.
30. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, Billiar TR. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. JEM 2005, 201:1135-1143.
31. Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N, Ekong U, Dun H, Lu Y, Qu W, Schmidt AM, Emond JC. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 2004, 39:422-432. 10.1002/hep.20045, 14767995.
32. Vaquero J, Belanger M, James L, et al. Mild hypothermia attenuates liver injury and improves survival in mice with acetaminophen toxicity. Gastroenterology 2007, 132:372-408. 10.1053/j.gastro.2006.11.025, 17241886.
33. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 2006, 43:S31-44. 10.1002/hep.21062, 16447272.
34. Ulloa L, Ochani M, Yang H, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci 2002, 99:12351-12356. 10.1073/pnas.192222999, 129448, 12209006.
35. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grishma JW, Brenner DA. NF kappa B prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998, 101:802-811. 10.1172/JCI483, 508628, 9466975.
36. Kaplowitz N. Acetaminophen hepatotoxicity. What do we know, what don't we know, and what do we do next?. Hepatology 2004, 40:23-6.
37. Milesi-Halle A, McCullough S, Hinson JA, et al. Echinomycin decreases induction of vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity in mice. Basic Clin Pharmacol Toxicol 2011,
38. Gardner CR, Gray JP, Joseph LB, et al. Potential role of caveolin-1 in acetaminophen-induced hepatotoxicity. Toxicol Appl Pharmacol 2010, 245:36-46. 10.1016/j.taap.2010.01.008, 2862893, 20100502.
39. Whyte IM, Francis B, Dawson AH. Safety and efficacy of intravenous N- acetylcystine for acetaminophen overdose: analysis of the Hunter Area Toxicity service (HATS) Database. Current Medical Research and Opinion 2007, 23:2359-2368. 10.1185/030079907X219715, 17705945.
40. Kerr F, Dawson A, Whyte IH, Buckley N, Murray L, Graudins A, Chan B, Trudinger B. The austrilian clinical toxicology investigators collaboration Randomized trial of different loading infusion rates of N-acetylcystine. Annals of Emergency Med 2005, 45:402-408.